nicergoline has been researched along with Brain Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fioravanti, M; Garg, A; Nakashima, T; Xu, J | 1 |
| Damulin, IV | 1 |
2 review(s) available for nicergoline and Brain Diseases
| Article | Year |
|---|---|
A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline.
Topics: Adrenergic alpha-Antagonists; Brain Diseases; Humans; Neuroprotective Agents; Nicergoline; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic | 2014 |
[Therapeutic potential and possibilities of using of sermion (nicergoline) in neurological practice].
Topics: Adrenergic alpha-Antagonists; Brain Diseases; Dementia; Humans; Nicergoline; Nootropic Agents; Vasodilator Agents | 2010 |